Dermatologic

Very common (10% or more): Excoriation/flaking/scaling/dryness (up to 87%), erythema (up to 69%), scab/crusting (up to 64%), erosion/ulceration (up to 54%), skin exfoliation, skin edema, skin ulcer, skin hypopigmentation

Common (1% to 10%): Dermatitis

Uncommon (0.1% to 1%): Pruritus, folliculitis, rash erythematous, eczema, rash, sweating increased, urticaria, actinic keratosis

Frequency not reported: Skin infection, alopecia, erythema multiforme, Stevens-Johnson syndrome, skin hyperpigmentation, cutaneous lupus erythematosus

Talk with your dermatologist about concerns

If you have any concerns about using imiquimod, you should tell your dermatologist. aldara-cream.today Dermatologists have been prescribing this medicine for years. In fact, dermatologists led many of the clinical trials for imiquimod. This makes dermatologists very familiar with the medicine and knowledgeable about whom it can help.

Before talking about concerns, it may be helpful to know the advantages and disadvantages of using this medicine, which are shown below.

Dermatologists continue to lead research studies that look at how much imiquimod can help improve the lives of their patients.

How is Aldara used?

The number of times Aldara is applied and the duration of treatment depend on the condition being treated.

• For genital warts, Aldara is applied three times a week for up to 16 weeks.
• For small basal cell carcinomas, the cream is applied five times a week for six weeks.
• For actinic keratoses, it is applied three times a week, for one or two four-week courses, with four weeks between courses.

The cream is applied in a thin layer to the affected areas of skin before sleeping, so that it remains on the skin for a suitable length of time (about eight hours) before being washed off. For further information, see the package leaflet.

Imiquimod topical (Includes imiquimod topical) ↔ eczema

Moderate Potential Hazard, High plausibility. http://en.m.wikipedia.org/wiki/Imiquimod Applies to: Eczema

Imiquimod may exacerbate inflammatory conditions of the skin. Local reactions are commonly associated with the use of imiquimod and may extend beyond the application site onto the surrounding skin. These reactions include erythema, edema, vesicles, erosion/ulceration, weeping/exudate, flaking/scaling/dryness, and scabbing/crusting. Therapy with topical imiquimod should be avoided or used with caution in patients with eczematous conditions.